• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸苷酸合成酶5'-非翻译增强区的3R变体与结直肠癌风险相关:一项荟萃分析。

3R variant of thymidylate synthase 5'-untranslated enhanced region contributes to colorectal cancer risk: a meta-analysis.

作者信息

Lu Min, Sun Luhaoran, Yang Jing, Li Yue-Yao

机构信息

Department of Colorectal Surgery, the First Affiliated Hospital of China Medical University, Shenyang, China.

出版信息

Asian Pac J Cancer Prev. 2012;13(6):2605-10. doi: 10.7314/apjcp.2012.13.6.2605.

DOI:10.7314/apjcp.2012.13.6.2605
PMID:22938428
Abstract

BACKGROUND

Studies investigating the association of 2R/3R polymorphism in the thymidylate synthase 5'-untranslated enhanced region (TSER) and colorectal cancer (CRC) risk have reported conflicting results. Thus, a meta-analysis was performed to summarize the data on the potential association.

METHODS

Pubmed, Embase and CBM databases were searched for all available studies. Links between the TSER 2R/3R polymorphism and CRC risk were estimated by odds ratios (ORs) with 95% confidence intervals (CIs).

RESULTS

Seven case-control studies with a total of 2723 cases and 4030 controls were included in this meta-analysis. The results showed that the 3R variant of TSER 2R/3R polymorphism contributes to CRC risk in two comparison models (OR 3R vs. 2R =1.10, 95%CI 1.02-1.18, P = 0.015; OR Homozygote comparison model = 1.22 1.04-1.43, 95%CI 1.04- 1.43, P = 0.012). Subgroup analyses by ethnicity further demonstrated a contribution in Caucasians with three comparison models (OR 3R vs. 2R = 1.10, 95%CI 1.02-1.19, P = 0.015; OR Homozygote comparison model = 1.21, 95%CI 1.03-1.41, P = 0.019; OR Recessive comparison model = 1.18, 95%CI 1.05-1.33, P = 0.008). However, the association in the Asian population was still uncertain due to the limited data (all P values were more than 0.05).

CONCLUSIONS

Our meta-analysis suggests that the 3R variant of Thymidylate synthase 5'-untranslated enhanced region 2R/3R polymorphism contributes to gastric cancer risk in the Caucasian population, while any association in Asian populations needs further study.

摘要

背景

关于胸苷酸合成酶5'-非翻译增强区(TSER)的2R/3R多态性与结直肠癌(CRC)风险之间关联的研究报告结果相互矛盾。因此,进行了一项荟萃分析以总结有关潜在关联的数据。

方法

检索了Pubmed、Embase和CBM数据库中的所有可用研究。通过比值比(OR)及其95%置信区间(CI)评估TSER 2R/3R多态性与CRC风险之间的联系。

结果

本荟萃分析纳入了7项病例对照研究,共2723例病例和4030例对照。结果显示,在两种比较模型中,TSER 2R/3R多态性的3R变体与CRC风险相关(OR 3R vs. 2R =1.10,95%CI 1.02-1.18,P = 0.015;OR纯合子比较模型 = 1.22,95%CI 1.04-1.43,P = 0.012)。按种族进行的亚组分析进一步表明,在白种人的三种比较模型中存在关联(OR 3R vs. 2R = 1.10,95%CI 1.02-1.19,P = 0.015;OR纯合子比较模型 = 1.21,95%CI 1.03-1.41,P = 0.019;OR隐性比较模型 = 1.18,95%CI 1.05-1.通过比值比(OR)及其95%置信区间(CI)评估TSER 2R/3R多态性与CRC风险之间的联系。

结果

本荟萃分析纳入了7项病例对照研究,共2723例病例和4030例对照。结果显示,在两种比较模型中,TSER 2R/3R多态性的3R变体与CRC风险相关(OR 3R vs. 2R =1.10,95%CI 1.02-1.18,P = 0.015;OR纯合子比较模型 = 1.22,95%CI 1.04-1.43,P = 0.012)。按种族进行的亚组分析进一步表明,在白种人的三种比较模型中存在关联(OR 3R vs. 2R = 1.10,95%CI 1.02-1.19,P = 0.015;OR纯合子比较模型 = 1.21,95%CI 1.03-1.41,P = 0.019;OR隐性比较模型 = 1.18,95%CI 1.05-1.33,P = 0.008)。然而,由于数据有限,亚洲人群中的关联仍不确定(所有P值均大于0.05)。

结论

我们的荟萃分析表明,胸苷酸合成酶5'-非翻译增强区2R/3R多态性的3R变体与白种人群体的胃癌风险相关,而亚洲人群中的任何关联都需要进一步研究。

相似文献

1
3R variant of thymidylate synthase 5'-untranslated enhanced region contributes to colorectal cancer risk: a meta-analysis.胸苷酸合成酶5'-非翻译增强区的3R变体与结直肠癌风险相关:一项荟萃分析。
Asian Pac J Cancer Prev. 2012;13(6):2605-10. doi: 10.7314/apjcp.2012.13.6.2605.
2
2R of thymidylate synthase 5'-untranslated enhanced region contributes to gastric cancer risk: a meta-analysis.胸苷酸合成酶5'-非翻译增强区域的2R与胃癌风险相关:一项荟萃分析。
Asian Pac J Cancer Prev. 2012;13(5):1923-7. doi: 10.7314/apjcp.2012.13.5.1923.
3
Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.胸苷酸合成酶多态性与血液系统恶性肿瘤风险:一项荟萃分析。
Leuk Lymphoma. 2012 Jul;53(7):1345-51. doi: 10.3109/10428194.2011.649477. Epub 2012 Jan 31.
4
Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.胸苷酸合成酶启动子增强子区域的多态性改变了结直肠癌的风险和生存率。
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):958-62.
5
TSER polymorphism is not associated with risk of pediatric acute lymphoblastic leukemia: A meta-analysis.TSER多态性与小儿急性淋巴细胞白血病风险无关:一项荟萃分析。
Medicine (Baltimore). 2017 Feb;96(7):e6143. doi: 10.1097/MD.0000000000006143.
6
Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.胸苷酸合成酶基因 5'-和 3'-非翻译区多态性与韩国人胃癌风险的关系。
Anticancer Res. 2010 Jun;30(6):2325-30.
7
The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.TYMS 基因两个多态性与乳腺癌风险的关联:荟萃分析。
Breast Cancer Res Treat. 2011 Jul;128(1):203-9. doi: 10.1007/s10549-010-1314-0. Epub 2010 Dec 25.
8
Thymidylate synthase genetic polymorphisms and colorectal cancer risk: a meta-analysis.胸苷酸合成酶基因多态性与结直肠癌风险:一项荟萃分析。
Clin Res Hepatol Gastroenterol. 2014 Sep;38(4):481-90. doi: 10.1016/j.clinre.2014.02.006. Epub 2014 Mar 29.
9
Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.匈牙利结直肠癌患者胸苷酸合成酶增强子区域多态性基因型分布中的杂合子缺陷
Int J Cancer. 2004 Mar 1;108(6):852-6. doi: 10.1002/ijc.11641.
10
Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.胸苷酸合成酶5'和3'非翻译区多态性与头颈部鳞状细胞癌的风险及进展相关。
Clin Cancer Res. 2004 Dec 1;10(23):7903-10. doi: 10.1158/1078-0432.CCR-04-0923.

引用本文的文献

1
3'-UTR Polymorphisms in Thymidylate Synthase with Colorectal Cancer Prevalence and Prognosis.胸苷酸合成酶3'-非翻译区多态性与结直肠癌的患病率及预后
J Pers Med. 2021 Jun 9;11(6):537. doi: 10.3390/jpm11060537.
2
Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis.胸苷酸合成酶基因5'-和3'-非翻译区多态性与胃癌风险的关联:荟萃分析
Biosci Rep. 2016 Dec 23;36(6). doi: 10.1042/BSR20160273. Print 2016 Dec.
3
Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
SEPT9启动子甲基化状态、微核频率和叶酸相关基因多态性的同步分析:新型血液结直肠癌生物标志物的潜力
Int J Mol Sci. 2015 Dec 1;16(12):28486-97. doi: 10.3390/ijms161226113.
4
Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism.结直肠癌及癌旁正常黏膜组织中基因启动子甲基化:与生理病理特征及一碳代谢生物标志物的相关性研究。
Epigenetics. 2014 Apr;9(4):621-33. doi: 10.4161/epi.27956. Epub 2014 Jan 31.